• Poland & The Baltics

    Gilead Sciences Poland & The Baltics Sp. Z o. o.

    Adgar Plaza

    6th Floor

    ul. Postepu 17A

    02-676 Warszawa


    Phone: +48 222 628 702 +48 222 628 702

    Fax: +48 222 628 701

    Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases worldwide.

    Read more about Transparency Reporting

    Relationships with Charitable Organizations/Institutions

    Gilead provided support for the following charitable organizations in 2018. The information is correct at the time of writing (March 2019). The information is subject to change and periodic updates. For a listing of previous years’ grants, click here.

    Poland 2018 Spend

    Recipient Description of Activity Amount Funded PLN
    ALIVIA - FUNDACJA ONKOLOGICZNA OSóB M?ODYCH Grant for project: Kolejkoskop (3 months support). 21000
    FUNDACJA ?GWIAZDA NADZIEI” Grant for project: "Insidious Hepatitis" - knowledge workshops for students which will be organized from 10.10.2018 until 6.2019 in high schools. 30000
    SPO?ECZNY KOMITET DS. AIDS Grant for: "Holidays with the Little Prince" - rehabilitation and educational stay for children and adolescents living with HIV / AIDS. 20000
    STOWARZYSZENIE PODWALE SIEDEM Grant for project: Preventive and educational campaign "Live safer - or how to minimize the risk of HIV infection". 20000
    STOWARZYSZENIE WOLONTARIUSZY WOBEC AIDS "B?D? Z NAMI" Grant for project: "They are us"- HIV education and awareness campaign for infected people and their families. 20000

    Baltics 2018 Spend

    Patient Organisation Recipient Description of Activity Amount Funded €
    PEOPLE LIVING WITH HIV/AIDS SUPPORT GROUP (AGIHAS) Grant for Project: "25 years of Activism raise an Adherence", event will take place between 14-15.09.2018 in Riga. 2500

    This page is intended for visitors outside of the United States.